Bone Health and Impact of Tenofovir Treatment in Men with Hepatitis-B Related Chronic Liver Disease
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 8 (1) , 23-27
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Wilson′s disease: An endocrine revelationIndian Journal of Endocrinology and Metabolism, 2014
- Bone Pain Due to Fractures Revealing Osteomalacia Related to Tenofovir-Induced Proximal Renal Tubular Dysfunction in a Human Immunodeficiency Virus-Infected PatientJCR: Journal of Clinical Rheumatology, 2009
- Vitamin K and the Prevention of FracturesArchives of internal medicine (1960), 2006
- The RANKL/OPG system and bone mineral density in patients with chronic liver diseaseJournal of Hepatology, 2005
- Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal womenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- AGA technical review on osteoporosis in hepatic disordersGastroenterology, 2003
- Guidelines on the management of osteoporosis associated with chronic liver diseaseGut, 2002
- Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosisHepatology, 1998
- Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatmentJournal of Hepatology, 1998
- Hepatic osteodystrophyGastroenterology, 1989